Loss of Akt1 or Akt2 delays mammary tumor onset and suppresses tumor growth rate in MTB-IGFIR transgenic mice

The potential role of Akt phosphorylation in human cancers

(2017) J. Cicenas   INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS

Epithelial–mesenchymal transition and breast cancer: Role, molecular mechanisms and clinical impact

(2011) Chiara Foroni et al.   CANCER TREATMENT REVIEWS

RB1 and p53 at the crossroad of EMT and triple-negative breast cancer

(2011) Zhe Jiang et al.   CELL CYCLE

Temporal and Spatial Cooperation of Snail1 and Twist1 during Epithelial-Mesenchymal Transition Predicts for Human Breast Cancer Recurrence

(2011) D. D. Tran et al.   MOLECULAR CANCER RESEARCH

PI3K inhibition results in enhanced HER signaling and acquired ERK dependency in HER2-overexpressing breast cancer

(2011) V Serra et al.   ONCOGENE

The Transcription Factors Snail and Slug Activate the Transforming Growth Factor-Beta Signaling Pathway in Breast Cancer

(2011) Archana Dhasarathy et al.   PLoS One

Akt isoform-specific inhibition of MDA-MB-231 cell proliferation

(2010) Wonseok Yang et al.   CELLULAR SIGNALLING

Akt1 and Akt2 Play Distinct Roles in the Initiation and Metastatic Phases of Mammary Tumor Progression

(2009) R. L. Dillon et al.   CANCER RESEARCH

Igf1r as a therapeutic target in a mouse model of basal-like breast cancer

(2009) A. Klinakis et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA